During the past decade, Facharztzentrum Eppendorf, Studien GbR conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Facharztzentrum Eppendorf, Studien GbR" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Facharztzentrum Eppendorf, Studien GbR" are "B-cell Lymphoma" (1 trials), "Breast Cancer" (1 trials), "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials), "Estrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials) and "Gastric Cancer" (1 trials). Many other conditions were trialed in "Facharztzentrum Eppendorf, Studien GbR" in a lesser frequency.

Most popular intervention types in "Facharztzentrum Eppendorf, Studien GbR" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "trastuzumab emtansine" (2 trials), "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (1 trials), "Bevacizumab" (1 trials) and "CHOP" (1 trials). Other intervention names were less common.

The vast majority of trials in "Facharztzentrum Eppendorf, Studien GbR" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Facharztzentrum Eppendorf, Studien GbR". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Facharztzentrum Eppendorf, Studien GbR, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Facharztzentrum Eppendorf, Studien GbR, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".